Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 18 (6), 487-92

Inflammatory Cystoid Macular Edema


Inflammatory Cystoid Macular Edema

Aniki Rothova. Curr Opin Ophthalmol.


Purpose of review: The aim of this article is to update our current understanding and management of inflammatory cystoid macular edema.

Recent findings: Cystoid macular edema is a common cause of visual loss in uveitis, which occurs predominantly in older patients with chronic uveitis forms and might be heralded by subclinical changes on optic coherence tomography. Cystoid macular edema is emerging as a major cause of visual loss in HIV-infected patients with immune recovery uveitis. Elevated levels of proinflammatory cytokines and vascular endothelial growth factor were found in all types of cystoid macular edema. Treatment with anti-inflammatory and anti-vascular endothelial growth factor drugs is widely applied for all forms of cystoid macular edema and usually has a beneficial, but temporary effect. So far, there are no clear guidelines for the treatment of subclinical cystoid macular edema in uveitis. The effect of vitrectomy in inflammatory cystoid macular edema is not yet clear and might become more important in the future. Recent advances in management include intravitreal drug delivery systems of cystoid macular edema-modifying drugs.

Summary: This review summarizes current thoughts on inflammatory cystoid macular edema focusing on the new, clinically relevant findings. Upcoming data on aqueous constituents in cystoid macular edema and imaging with the new generation of optic coherence tomography offer the hope that a better treatment strategy will soon be established.

Similar articles

  • Cystoid macular edema as a result of immune-recovery uveitis.
    Guzak R, Rodman J, Pizzimenti J. Guzak R, et al. Optom Vis Sci. 2011 Feb;88(2):E344-51. doi: 10.1097/OPX.0b013e3182058fd6. Optom Vis Sci. 2011. PMID: 21217412
  • Clinical review: Update on treatment of inflammatory macular edema.
    Ossewaarde-van Norel A, Rothova A. Ossewaarde-van Norel A, et al. Ocul Immunol Inflamm. 2011 Feb;19(1):75-83. doi: 10.3109/09273948.2010.509530. Epub 2010 Oct 31. Ocul Immunol Inflamm. 2011. PMID: 21034302 Review.
  • Etiology and treatment of macular edema.
    Johnson MW. Johnson MW. Am J Ophthalmol. 2009 Jan;147(1):11-21.e1. doi: 10.1016/j.ajo.2008.07.024. Epub 2008 Sep 13. Am J Ophthalmol. 2009. PMID: 18789796 Review.
  • Macular edema.
    Tranos PG, Wickremasinghe SS, Stangos NT, Topouzis F, Tsinopoulos I, Pavesio CE. Tranos PG, et al. Surv Ophthalmol. 2004 Sep-Oct;49(5):470-90. doi: 10.1016/j.survophthal.2004.06.002. Surv Ophthalmol. 2004. PMID: 15325193 Review.
  • Pseudophakic cystoid macular edema.
    Yonekawa Y, Kim IK. Yonekawa Y, et al. Curr Opin Ophthalmol. 2012 Jan;23(1):26-32. doi: 10.1097/ICU.0b013e32834cd5f8. Curr Opin Ophthalmol. 2012. PMID: 22134362 Review.
See all similar articles

Cited by 19 articles

See all "Cited by" articles

MeSH terms

LinkOut - more resources